Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimated waste generation from 1 million basic metabolic panels: a multisite U.S. study.

Clinical chemistry and laboratory medicine·2025
Same author

ADLM 2025 Annual Meeting Abstracts: Where Science Meets Wonder.

Clinical chemistry·2025
Same author

Establishing and implementing a responsible artificial intelligence framework: a 1-year review.

Journal of the American Medical Informatics Association : JAMIA·2025
Same author

Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol.

Clinical chemistry·2025
Same author

Advances and Skepticism for Broad Implementation of Capillary Collection Devices.

The journal of applied laboratory medicine·2025
Same author

A Gradual Positive Bias in Chloride Measurements with a Major Automated Chemistry Platform.

The journal of applied laboratory medicine·2025
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Drug testing in the neonate.

Steven W Cotten1

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27514, USA. scotten@unch.unc.edu

Clinics in Laboratory Medicine
|September 4, 2012
PubMed
Summary
This summary is machine-generated.

Newborn drug testing presents analytical, legal, and therapeutic challenges. Understanding these limitations is crucial due to potential impacts on infant medical care and child welfare services.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Neurodevelopmental Reflex Testing in Neonatal Rat Pups
09:35

Neurodevelopmental Reflex Testing in Neonatal Rat Pups

Published on: April 24, 2017

Related Experiment Videos

Last Updated: May 19, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Neurodevelopmental Reflex Testing in Neonatal Rat Pups
09:35

Neurodevelopmental Reflex Testing in Neonatal Rat Pups

Published on: April 24, 2017

Area of Science:

  • Neonatal Medicine
  • Clinical Chemistry
  • Forensic Toxicology

Background:

  • Drug testing in newborns is complex, involving analytical, therapeutic, and legal considerations.
  • Interpretation of results requires expertise from physicians, nurses, and social services.
  • Unique challenges arise from the analytical and legal aspects of neonatal drug screening.

Purpose of the Study:

  • To highlight the analytical, therapeutic, and legal issues associated with newborn drug testing.
  • To emphasize the importance of understanding the limitations of these tests.
  • To discuss the implications for medical management and child welfare.

Main Methods:

  • Review of analytical and legal caveats in newborn drug testing.
  • Examination of therapeutic implications for managing neonatal withdrawal symptoms.
  • Analysis of legal ramifications and social services involvement.

Main Results:

  • Positive drug screens can guide medical management of neonatal withdrawal.
  • Legal issues and child safety assessments are triggered by positive urine or meconium samples.
  • Laboratory results have significant implications for parental rights and child custody.

Conclusions:

  • The caveats and limitations of drug testing in newborns are critically important.
  • Accurate interpretation is essential to ensure appropriate medical care and legal processes.
  • Testing can lead to the separation of newborns from biological parents, underscoring the need for careful consideration.